long-term effects of glp-1 receptor agonists The cardiovascular beyond obesity and type 2 diabetes: An anti-atherosclerotic action Glucagon-like peptide 1(GLP-1) receptor agonists
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 75
In: Stoker TB, Greenland JC, editors
Strokes are mainly divided into hemorrhagic and ischemic strokes caused by blood vessel obstruction
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
J Neurol Sci
In 2021, the FDA stamped its approval on high-dose semaglutide under the brand name Wegovy, officially giving doctors a new heavyweight contender for chronic weight management
